{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T21:57:15Z","timestamp":1770242235898,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00393-025-01770-5","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T14:47:43Z","timestamp":1767883663000},"page":"14-25","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gemeinsame patientenorientierte Versorgung\u00a0\u2013 erste interdisziplin\u00e4re S2k-Leitlinie zum juvenilen systemischen Lupus erythematodes","Joint patient-oriented care\u2014First interdisciplinary S2-k guidelines on juvenile systemic lupus erythematodes"],"prefix":"10.1007","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9409-441X","authenticated-orcid":false,"given":"Kirsten","family":"M\u00f6nkem\u00f6ller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catharina","family":"Sch\u00fctz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"Haffner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Tenbrock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"1770_CR1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/1756-185x.12419","volume":"18","author":"A Aggarwal","year":"2015","unstructured":"Aggarwal\u00a0A, Srivastava\u00a0P (2015) Childhood onset systemic lupus erythematosus: how is it different from adult SLE? Int J Rheum Dis 18:182\u2013191. https:\/\/doi.org\/10.1111\/1756-185x.12419","journal-title":"Int J Rheum Dis"},{"key":"1770_CR2","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s11882-024-01169-3","volume":"24","author":"A Aggarwal","year":"2024","unstructured":"Aggarwal\u00a0A, Fernandes\u00a0TAP, Migowa\u00a0A et\u00a0al (2024) Childhood-Onset Systemic Lupus Erythematosus (cSLE): An International Perspective. Curr Allergy Asthma Rep 24:559\u2013569. https:\/\/doi.org\/10.1007\/s11882-024-01169-3","journal-title":"Curr Allergy Asthma Rep"},{"key":"1770_CR3","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1177\/0961203316644333","volume":"25","author":"N Ambrose","year":"2016","unstructured":"Ambrose\u00a0N, Morgan\u00a0TA, Galloway\u00a0J et\u00a0al (2016) Differences in disease phenotype and severity in SLE across age groups. Lupus 25:1542\u20131550. https:\/\/doi.org\/10.1177\/0961203316644333","journal-title":"Lupus"},{"key":"1770_CR4","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","volume":"76","author":"L Andreoli","year":"2017","unstructured":"Andreoli\u00a0L, Bertsias\u00a0GK, Agmon-Levin\u00a0N et\u00a0al (2017) EULAR recommendations for women\u2019s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome. Ann Rheum Dis 76:476. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209770","journal-title":"Ann Rheum Dis"},{"key":"1770_CR5","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3899\/jrheum.160340","volume":"44","author":"B Artim-Esen","year":"2017","unstructured":"Artim-Esen\u00a0B, \u015eahin\u00a0S, \u00c7ene\u00a0E et\u00a0al (2017) Comparison of Disease Characteristics, Organ Damage, and Survival in Patients with Juvenile-onset and Adult-onset Systemic Lupus Erythematosus in a\u00a0Combined Cohort from 2 Tertiary Centers in Turkey. J\u00a0Rheumatol 44:619\u2013625. https:\/\/doi.org\/10.3899\/jrheum.160340","journal-title":"J Rheumatol"},{"key":"1770_CR6","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.3390\/children10061006","volume":"10","author":"J Blamires","year":"2023","unstructured":"Blamires\u00a0J, Foster\u00a0M, Napier\u00a0S, Dickinson\u00a0A (2023) Experiences and Perspectives of Children and Young People Living with Childhood-Onset Systemic Lupus Erythematosus\u2014An Integrative Review. Children 10:1006. https:\/\/doi.org\/10.3390\/children10061006","journal-title":"Children"},{"key":"1770_CR7","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/art.23204","volume":"58","author":"HI Brunner","year":"2008","unstructured":"Brunner\u00a0HI, Gladman\u00a0DD, Iba\u00f1ez\u00a0D et\u00a0al (2008) Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum 58:556\u2013562. https:\/\/doi.org\/10.1002\/art.23204","journal-title":"Arthritis Rheum"},{"key":"1770_CR8","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1136\/annrheumdis-2018-213198","volume":"78","author":"HI Brunner","year":"2019","unstructured":"Brunner\u00a0HI, Martini\u00a0A, Lovell\u00a0DJ et\u00a0al (2019) Clinical trials in children and adolescents with systemic lupus erythematosus: methodological aspects, regulatory landscape and future opportunities. Ann Rheum Dis 78:162. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213198","journal-title":"Ann Rheum Dis"},{"key":"1770_CR9","doi-asserted-by":"publisher","first-page":"e000817","DOI":"10.1136\/lupus-2022-000817","volume":"10","author":"HI Brunner","year":"2023","unstructured":"Brunner\u00a0HI, Vadhariya\u00a0A, Dickson\u00a0C et\u00a0al (2023) Treatment patterns in paediatric and adult patients with SLE: a\u00a0retrospective claims database study in the USA. Lupus Sci Med 10:e817. https:\/\/doi.org\/10.1136\/lupus-2022-000817","journal-title":"Lupus Sci Med"},{"key":"1770_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11926-021-00985-0","volume":"23","author":"A Charras","year":"2021","unstructured":"Charras\u00a0A, Smith\u00a0E, Hedrich\u00a0CM (2021) Systemic Lupus Erythematosus in Children and Young People. Curr Rheumatol Rep 23:20. https:\/\/doi.org\/10.1007\/s11926-021-00985-0","journal-title":"Curr Rheumatol Rep"},{"key":"1770_CR11","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1016\/s2665-9913(24)00085-7","volume":"6","author":"C Ciurtin","year":"2024","unstructured":"Ciurtin\u00a0C, Robinson\u00a0G, Butt\u00a0M et\u00a0al (2024) Cardiovascular risk in young people with childhood onset systemic lupus erythematosus. Lancet Rheumatol 6:e258\u2013e263. https:\/\/doi.org\/10.1016\/s2665-9913(24)00085-7","journal-title":"Lancet Rheumatol"},{"key":"1770_CR12","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/ard-2022-223741","volume":"82","author":"MK Crow","year":"2023","unstructured":"Crow\u00a0MK (2023) Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets. Ann Rheum Dis 82:999\u20131014. https:\/\/doi.org\/10.1136\/ard-2022-223741","journal-title":"Ann Rheum Dis"},{"key":"1770_CR13","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1093\/ndt\/gfab152","volume":"37","author":"S Demir","year":"2021","unstructured":"Demir\u00a0S, G\u00fclhan\u00a0B, \u00d6zen\u00a0S et\u00a0al (2021) Long-term renal survival of paediatric patients with lupus nephritis. Nephrol Dial Transplant 37:1069\u20131077. https:\/\/doi.org\/10.1093\/ndt\/gfab152","journal-title":"Nephrol Dial Transplant"},{"key":"1770_CR14","unstructured":"DGRh DG f\u00fcr R und KI Management des systemischen Lupus erythematodes inklusive sekund\u00e4rem Antiphospholipid-Syndrom, Kinderwunsch und Schwangerschaft"},{"key":"1770_CR15","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-057978","author":"SM Eaton","year":"2022","unstructured":"Eaton\u00a0SM, Clark\u00a0JD, Cummings\u00a0CL et\u00a0al (2022) Pediatric Shared Decision-Making for Simple and Complex Decisions: Findings From a\u00a0Delphi Panel. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2022-057978","journal-title":"Pediatrics"},{"key":"1770_CR16","doi-asserted-by":"publisher","first-page":"e000310","DOI":"10.1136\/lupus-2018-000310","volume":"6","author":"A Fanouriakis","year":"2019","unstructured":"Fanouriakis\u00a0A, Bertsias\u00a0G (2019) Changing paradigms in the treatment of systemic lupus erythematosus. Lupus Sci Med 6:e310. https:\/\/doi.org\/10.1136\/lupus-2018-000310","journal-title":"Lupus Sci Med"},{"key":"1770_CR17","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1177\/09612033231191944","volume":"32","author":"A Fanouriakis","year":"2023","unstructured":"Fanouriakis\u00a0A, Bertsias\u00a0G, Liapis\u00a0G et\u00a0al (2023) Multidisciplinary approach to lupus nephritis: Clinical pearls, pitfalls, and positioning of newly-approved agents. Lupus 32:1155\u20131163. https:\/\/doi.org\/10.1177\/09612033231191944","journal-title":"Lupus"},{"key":"1770_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/ard-2023-224762","volume":"83","author":"A Fanouriakis","year":"2024","unstructured":"Fanouriakis\u00a0A, Kostopoulou\u00a0M, Andersen\u00a0J et\u00a0al (2024) EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis 83:15\u201329. https:\/\/doi.org\/10.1136\/ard-2023-224762","journal-title":"Ann Rheum Dis"},{"key":"1770_CR19","doi-asserted-by":"publisher","first-page":"105523","DOI":"10.1016\/j.jbspin.2023.105523","volume":"90","author":"R Felten","year":"2023","unstructured":"Felten\u00a0R, Scherlinger\u00a0M, Mertz\u00a0P et\u00a0al (2023) New biologics and targeted therapies in systemic lupus: From new molecular targets to new indications. A\u00a0systematic review. Jt Bone Spine 90:105523. https:\/\/doi.org\/10.1016\/j.jbspin.2023.105523","journal-title":"Jt Bone Spine"},{"key":"1770_CR20","volume-title":"S2k-Leitlinie \u201eInterdisziplin\u00e4re Leitlinie des Systemischen Lupus erythematodes (SLE) mit Beginn im Kindes- und Jugendalter\u201c","author":"GKJR","year":"2025","unstructured":"GKJR, GPN, DGKJ (2025) S2k-Leitlinie \u201eInterdisziplin\u00e4re Leitlinie des Systemischen Lupus erythematodes (SLE) mit Beginn im Kindes- und Jugendalter\u201c"},{"key":"1770_CR21","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1007\/s10067-024-07101-4","volume":"43","author":"R Gotch","year":"2024","unstructured":"Gotch\u00a0R, Ahmed\u00a0Y, Wilson\u00a0R et\u00a0al (2024) Active implementation of low disease activity state as a\u00a0treatment endpoint in childhood-onset systemic lupus erythematosus in routine practice is both feasible and associated with better outcomes. Clin Rheumatol 43:3231\u20133238. https:\/\/doi.org\/10.1007\/s10067-024-07101-4","journal-title":"Clin Rheumatol"},{"key":"1770_CR22","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1136\/annrheumdis-2016-210960","volume":"76","author":"N Groot","year":"2017","unstructured":"Groot\u00a0N, de Graeff\u00a0N, Avcin\u00a0T et\u00a0al (2017) European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative. Ann Rheum Dis 76:1788\u20131796. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210960","journal-title":"Ann Rheum Dis"},{"key":"1770_CR23","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/art.40697","volume":"71","author":"N Groot","year":"2019","unstructured":"Groot\u00a0N, Shaikhani\u00a0D, Teng\u00a0YKO et\u00a0al (2019) Long-Term Clinical Outcomes in a\u00a0Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus. Arthritis Rheumatol 71:290\u2013301. https:\/\/doi.org\/10.1002\/art.40697","journal-title":"Arthritis Rheumatol"},{"key":"1770_CR24","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2023.09.002","volume":"105","author":"BH Rovin","year":"2024","unstructured":"Group KDIGO (KDIGO) LNW, Rovin\u00a0BH, Ayoub\u00a0IM et\u00a0al (2024) KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS. Kidney Int 105:S1\u2013S69. https:\/\/doi.org\/10.1016\/j.kint.2023.09.002","journal-title":"Kidney Int"},{"key":"1770_CR25","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1002\/art.22048","volume":"54","author":"R Guti\u00e9rrez-Su\u00e1rez","year":"2006","unstructured":"Guti\u00e9rrez-Su\u00e1rez\u00a0R, Ruperto\u00a0N, Gastaldi\u00a0R et\u00a0al (2006) A proposal for a\u00a0pediatric version of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology Damage Index based on the analysis of 1,015 patients with juvenile-onset systemic lupus erythematosus. Arthritis Rheum 54:2989\u20132996. https:\/\/doi.org\/10.1002\/art.22048","journal-title":"Arthritis Rheum"},{"key":"1770_CR26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.semarthrit.2019.05.010","volume":"49","author":"M Heshin-Bekenstein","year":"2019","unstructured":"Heshin-Bekenstein\u00a0M, Trupin\u00a0L, Yelin\u00a0E et\u00a0al (2019) Longitudinal disease- and steroid-related damage among adults with childhood-onset systemic lupus erythematosus. Semin Arthritis Rheum 49:267\u2013272. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.05.010","journal-title":"Semin Arthritis Rheum"},{"key":"1770_CR27","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1002\/acr.23531","volume":"70","author":"MJ Holland","year":"2018","unstructured":"Holland\u00a0MJ, Beresford\u00a0MW, Feldman\u00a0BM et\u00a0al (2018) Measuring Disease Damage and Its Severity in Childhood-Onset Systemic Lupus Erythematosus. Arthritis Care Res 70:1621\u20131629. https:\/\/doi.org\/10.1002\/acr.23531","journal-title":"Arthritis Care Res"},{"key":"1770_CR28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000518321","volume":"183","author":"X Huang","year":"2022","unstructured":"Huang\u00a0X, Jia\u00a0N, Xiao\u00a0F et\u00a0al (2022) Differences in the Clinical Manifestations and Mortality of Systemic Lupus Erythematosus Onset in Children and Adults: A\u00a0Systematic Review and Meta-Analysis. Int Arch Allergy Immunol 183:116\u2013126. https:\/\/doi.org\/10.1159\/000518321","journal-title":"Int Arch Allergy Immunol"},{"key":"1770_CR29","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1002\/acr.20623","volume":"63","author":"B Lattanzi","year":"2011","unstructured":"Lattanzi\u00a0B, Consolaro\u00a0A, Solari\u00a0N et\u00a0al (2011) Measures of disease activity and damage in pediatric systemic lupus erythematosus: British Isles Lupus Assessment Group (BILAG), European Consensus Lupus Activity Measurement (ECLAM), Systemic Lupus Activity Measure (SLAM), Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), Physician\u2019s Global Assessment of Disease Activity (MD Global), and Systemic Lupus International Collaborating Clinics\/American College of Rheumatology Damage Index (SLICC\/ACR DI; SDI). Arthritis Care Res 63:S112\u2013S117. https:\/\/doi.org\/10.1002\/acr.20623","journal-title":"Arthritis Care Res"},{"key":"1770_CR30","doi-asserted-by":"publisher","first-page":"1583140","DOI":"10.3389\/fmed.2025.1583140","volume":"12","author":"RD Lisa","year":"2025","unstructured":"Lisa\u00a0RD, de Andres-Trelles\u00a0F, Bax\u00a0R et\u00a0al (2025) New medicines for childhood-onset systemic lupus erythematosus: an EU perspective on paediatric drug development. Front Med 12:1583140. https:\/\/doi.org\/10.3389\/fmed.2025.1583140","journal-title":"Front Med"},{"key":"1770_CR31","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1177\/0961203320909156","volume":"29","author":"JS Massias","year":"2019","unstructured":"Massias\u00a0JS, Smith\u00a0EMD, Al-Abadi\u00a0E et\u00a0al (2019) Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups. Lupus 29:474\u2013481. https:\/\/doi.org\/10.1177\/0961203320909156","journal-title":"Lupus"},{"key":"1770_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12969-021-00513-5","volume":"19","author":"PBS Medeiros","year":"2021","unstructured":"Medeiros\u00a0PBS, Salom\u00e3o\u00a0RG, Teixeira\u00a0SR et\u00a0al (2021) Disease activity index is associated with subclinical atherosclerosis in childhood-onset systemic lupus erythematosus. Pediatr Rheumatol 19:35. https:\/\/doi.org\/10.1186\/s12969-021-00513-5","journal-title":"Pediatr Rheumatol"},{"key":"1770_CR33","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1093\/rheumatology\/kead519","volume":"63","author":"SR Moe","year":"2023","unstructured":"Moe\u00a0SR, Haukeland\u00a0H, Brunborg\u00a0C et\u00a0al (2023) Persisting mortality gap in systemic lupus erythematosus; a\u00a0population-based study on juvenile- and adult-onset SLE in Norway 1999\u20132022. Baillieres Clin Rheumatol 63:2109\u20132117. https:\/\/doi.org\/10.1093\/rheumatology\/kead519","journal-title":"Baillieres Clin Rheumatol"},{"issue":"4","key":"1770_CR34","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.ero.2025.10.005","volume":"1","author":"K M\u00f6nkem\u00f6ller","year":"2025","unstructured":"M\u00f6nkem\u00f6ller\u00a0K, Weber\u00a0L, H\u00e4usler\u00a0M (2025) Interdisciplinary Clinical Practice Guidelines for patient-centered management of juvenile-onset systemic lupus erythematosus. EULAR Rheumatol Open 1(4):380\u2013393. https:\/\/doi.org\/10.1016\/j.ero.2025.10.005","journal-title":"EULAR Rheumatol Open"},{"key":"1770_CR35","doi-asserted-by":"publisher","unstructured":"Ogbu EA, Sagcal-Gironella ACP, Eberhard BA, et al. (2025) Implementation of the Lupus Low Disease Activity State in Pediatric Rheumatology Care: The Role of the Visual Analog Scale. ACR Open Rheumatol 7(1):e11737. https:\/\/doi.org\/10.1002\/acr2.11737","DOI":"10.1002\/acr2.11737"},{"key":"1770_CR36","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/bor.0000000000001008","volume":"36","author":"Y Qin","year":"2024","unstructured":"Qin\u00a0Y, Ma\u00a0J, Vinuesa\u00a0CG (2024) Monogenic lupus: insights into disease pathogenesis and therapeutic opportunities. Curr Opin Rheumatol 36:191\u2013200. https:\/\/doi.org\/10.1097\/bor.0000000000001008","journal-title":"Curr Opin Rheumatol"},{"key":"1770_CR37","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"BH Rovin","year":"2021","unstructured":"Rovin\u00a0BH, Group KDIGO (KDIGO) GDW, Adler\u00a0SG et\u00a0al (2021) KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int 100:S1\u2013S276. https:\/\/doi.org\/10.1016\/j.kint.2021.05.021","journal-title":"Kidney Int"},{"key":"1770_CR38","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1093\/ndt\/gfs589","volume":"28","author":"B Ruggiero","year":"2013","unstructured":"Ruggiero\u00a0B, Vivarelli\u00a0M, Gianviti\u00a0A et\u00a0al (2013) Lupus nephritis in children and adolescents: results of the Italian Collaborative Study. Nephrol Dial Transplant 28:1487\u20131496. https:\/\/doi.org\/10.1093\/ndt\/gfs589","journal-title":"Nephrol Dial Transplant"},{"key":"1770_CR39","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1136\/ard-2024-226528","volume":"84","author":"RE Sadun","year":"2024","unstructured":"Sadun\u00a0RE, Cooper\u00a0JC, Belot\u00a0A et\u00a0al (2024) Development of CARRA\/PReS-endorsed consensus Core and Expanded Datasets in childhood-onset systemic lupus erythematosus for international registry-based research. Ann Rheum Dis 84:2024\u2013226528. https:\/\/doi.org\/10.1136\/ard-2024-226528","journal-title":"Ann Rheum Dis"},{"key":"1770_CR40","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/rhu.0000000000001029","volume":"27","author":"FPST Santos","year":"2021","unstructured":"Santos\u00a0FPST, Nascimento\u00a0BR, Calderaro\u00a0DC et\u00a0al (2021) Neuropsychiatric Syndromes in Childhood-Onset Systemic Lupus. Erythematosus Jcr: J Clin Rheumatol 27:206\u2013214. https:\/\/doi.org\/10.1097\/rhu.0000000000001029","journal-title":"Erythematosus Jcr: J Clin Rheumatol"},{"key":"1770_CR41","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1093\/rheumatology\/keaf057","volume":"64","author":"C Sarker","year":"2025","unstructured":"Sarker\u00a0C, Jorgensen\u00a0AL, Tharmaratnam\u00a0K et\u00a0al (2025) Validation of childhood lupus specific targets: ensuring accurate assessment of disease control in younger, lighter paediatric patients. Baillieres Clin Rheumatol 64:3587\u20133597. https:\/\/doi.org\/10.1093\/rheumatology\/keaf057","journal-title":"Baillieres Clin Rheumatol"},{"key":"1770_CR42","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1177\/09612033221115974","volume":"31","author":"R Semo-Oz","year":"2022","unstructured":"Semo-Oz\u00a0R, Wagner-Weiner\u00a0L, Edens\u00a0C et\u00a0al (2022) Adherence to medication by adolescents and young adults with childhood-onset systemic lupus erythematosus. Lupus 31:1508\u20131515. https:\/\/doi.org\/10.1177\/09612033221115974","journal-title":"Lupus"},{"key":"1770_CR43","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1002\/acr.21757","volume":"64","author":"CA Silva","year":"2012","unstructured":"Silva\u00a0CA, Avcin\u00a0T, Brunner\u00a0HI (2012) Taxonomy for systemic lupus erythematosus with onset before adulthood. Arthritis Care Res 64:1787\u20131793. https:\/\/doi.org\/10.1002\/acr.21757","journal-title":"Arthritis Care Res"},{"key":"1770_CR44","doi-asserted-by":"publisher","first-page":"109296","DOI":"10.1016\/j.clim.2023.109296","volume":"250","author":"EMD Smith","year":"2023","unstructured":"Smith\u00a0EMD, Aggarwal\u00a0A, Ainsworth\u00a0J et\u00a0al (2023) PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS). Clin Immunol 250:109296. https:\/\/doi.org\/10.1016\/j.clim.2023.109296","journal-title":"Clin Immunol"},{"key":"1770_CR45","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1136\/ard-2022-223328","volume":"82","author":"EMD Smith","year":"2023","unstructured":"Smith\u00a0EMD, Aggarwal\u00a0A, Ainsworth\u00a0J et\u00a0al (2023) Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force. Ann Rheum Dis 82:788\u2013798. https:\/\/doi.org\/10.1136\/ard-2022-223328","journal-title":"Ann Rheum Dis"},{"key":"1770_CR46","doi-asserted-by":"publisher","first-page":"110214","DOI":"10.1016\/j.clim.2024.110214","volume":"263","author":"EMD Smith","year":"2024","unstructured":"Smith\u00a0EMD, Aggarwal\u00a0A, Ainsworth\u00a0J et\u00a0al (2024) Defining remission in childhood-onset lupus: PReS-endorsed consensus definitions by an international task force. Clin Immunol 263:110214. https:\/\/doi.org\/10.1016\/j.clim.2024.110214","journal-title":"Clin Immunol"},{"key":"1770_CR47","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s00467-020-04501-x","volume":"35","author":"A Suhlrie","year":"2020","unstructured":"Suhlrie\u00a0A, Hennies\u00a0I, Gellermann\u00a0J et\u00a0al (2020) Twelve-month outcome in juvenile proliferative lupus nephritis: results of the German registry study. Pediatr Nephrol 35:1235\u20131246. https:\/\/doi.org\/10.1007\/s00467-020-04501-x","journal-title":"Pediatr Nephrol"},{"key":"1770_CR48","doi-asserted-by":"publisher","first-page":"e000123","DOI":"10.1136\/lupus-2015-000123","volume":"2","author":"F Tamirou","year":"2015","unstructured":"Tamirou\u00a0F, Lauwerys\u00a0BR, Dall\u2019Era\u00a0M et\u00a0al (2015) A proteinuria cut-off level of 0.7\u202fg\/day after 12\u00a0months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial. Lupus Sci Med 2:e123. https:\/\/doi.org\/10.1136\/lupus-2015-000123","journal-title":"Lupus Sci Med"},{"key":"1770_CR49","first-page":"1047","volume":"35","author":"V Torrente-Segarra","year":"2017","unstructured":"Torrente-Segarra\u00a0V, Monte\u00a0TCS, R\u00faa-Figueroa\u00a0I et\u00a0al (2017) Juvenile- and adult-onset systemic lupus erythematosus: a\u00a0comparative study in a\u00a0large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER). Clin Exp Rheumatol 35:1047\u20131055","journal-title":"Clin Exp Rheumatol"},{"key":"1770_CR50","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s40272-021-00457-z","volume":"23","author":"VC Trindade","year":"2021","unstructured":"Trindade\u00a0VC, Carneiro-Sampaio\u00a0M, Bonfa\u00a0E, Silva\u00a0CA (2021) An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus. Pediatr Drugs 23:331\u2013347. https:\/\/doi.org\/10.1007\/s40272-021-00457-z","journal-title":"Pediatr Drugs"},{"key":"1770_CR51","doi-asserted-by":"publisher","first-page":"851998","DOI":"10.3389\/fped.2022.851998","volume":"10","author":"K Vollbach","year":"2022","unstructured":"Vollbach\u00a0K, Schuetz\u00a0C, Hedrich\u00a0CM et\u00a0al (2022) Working Towards a\u00a0Treat-to-Target Protocol in Juvenile Proliferative Lupus Nephritis\u2014A Survey of Pediatric Rheumatologists and Nephrologists in Germany and Austria. Front Pediatr 10:851998. https:\/\/doi.org\/10.3389\/fped.2022.851998","journal-title":"Front Pediatr"},{"key":"1770_CR52","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s00431-021-04055-6","volume":"180","author":"RO Wijngaarde","year":"2021","unstructured":"Wijngaarde\u00a0RO, Hein\u00a0I, Daams\u00a0J et\u00a0al (2021) Chronically ill children\u2019s participation and health outcomes in shared decision-making: a\u00a0scoping review. Eur J Pediatr 180:2345\u20132357. https:\/\/doi.org\/10.1007\/s00431-021-04055-6","journal-title":"Eur J Pediatr"},{"key":"1770_CR53","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.semarthrit.2013.07.005","volume":"43","author":"J-Y Wu","year":"2014","unstructured":"Wu\u00a0J\u2011Y, Yeh\u00a0K\u2011W, Huang\u00a0J\u2011L (2014) Early predictors of outcomes in pediatric lupus nephritis: Focus on proliferative lesions. Semin Arthritis Rheum 43:513\u2013520. https:\/\/doi.org\/10.1016\/j.semarthrit.2013.07.005","journal-title":"Semin Arthritis Rheum"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-025-01770-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-025-01770-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-025-01770-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T09:14:27Z","timestamp":1770196467000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-025-01770-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1770"],"URL":"https:\/\/doi.org\/10.1007\/s00393-025-01770-5","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"K.\u00a0M\u00f6nkem\u00f6ller, C.\u00a0Sch\u00fctz, D.\u00a0Haffner und K.\u00a0Tenbrock geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}